Editorial: Mass spectrometry-based proteomics in drug discovery and development.
作者信息
Pejchinovski Martin, Magalhães Pedro, Metzger Jochen
机构信息
Department of Analytical Instruments Group, Thermo Fisher Scientific, Germering, Germany.
VIB KU Leuven Center for Brain & Disease Research, Leuven, Belgium.
出版信息
Front Med (Lausanne). 2024 Jul 23;11:1448152. doi: 10.3389/fmed.2024.1448152. eCollection 2024.
Abstract
摘要
相似文献
1
Editorial: Mass spectrometry-based proteomics in drug discovery and development.社论：基于质谱的蛋白质组学在药物发现与开发中的应用
Front Med (Lausanne). 2024 Jul 23;11:1448152. doi: 10.3389/fmed.2024.1448152. eCollection 2024.
2
The application of mass spectrometry to proteomics and metabolomics in biomarker discovery and drug development.质谱在生物标志物发现和药物开发中的蛋白质组学和代谢组学中的应用。
Curr Mol Pharmacol. 2012 Jun;5(2):301-16. doi: 10.2174/1874467211205020301.
3
Preparation and Immunoaffinity Depletion of Fresh Frozen Tissue Homogenates for Mass Spectrometry-Based Proteomics in the Context of Drug Target/Biomarker Discovery.在药物靶点/生物标志物发现背景下，用于基于质谱的蛋白质组学的新鲜冷冻组织匀浆的制备及免疫亲和去除。
Methods Mol Biol. 2017;1647:71-90. doi: 10.1007/978-1-4939-7201-2_5.
4
MALDI mass Spectrometry based proteomics for drug discovery & development.基于 MALDI 质谱的蛋白质组学在药物发现和开发中的应用。
Drug Discov Today Technol. 2021 Dec;40:29-35. doi: 10.1016/j.ddtec.2021.09.002. Epub 2021 Oct 23.
5
Mass spectrometry-based biomarker discovery: toward a global proteome index of individuality.基于质谱的生物标志物发现：走向个体的全球蛋白质组索引。
Annu Rev Anal Chem (Palo Alto Calif). 2009;2:265-77. doi: 10.1146/annurev.anchem.1.031207.112942.
6
Mass Spectrometry-Based Proteomics for Biomarker Discovery.基于质谱的蛋白质组学用于生物标志物发现。
Methods Mol Biol. 2022;2486:3-17. doi: 10.1007/978-1-0716-2265-0_1.
7
Mass Spectrometry-Based Biomarkers in Drug Development.基于质谱的药物研发生物标志物。
Adv Exp Med Biol. 2019;1140:435-449. doi: 10.1007/978-3-030-15950-4_25.
8
Proteomics applications in biomarker discovery and pathogenesis for abdominal aortic aneurysm.蛋白质组学在腹主动脉瘤生物标志物发现和发病机制中的应用。
Expert Rev Proteomics. 2021 Apr;18(4):305-314. doi: 10.1080/14789450.2021.1916473. Epub 2021 May 4.
9
Application of mass spectrometry-based proteomics for biomarker discovery in neurological disorders.基于质谱的蛋白质组学在神经疾病生物标志物发现中的应用。
Ann Indian Acad Neurol. 2009 Jan;12(1):3-11. doi: 10.4103/0972-2327.48845.
10
Mass spectrometry-assisted gel-based proteomics in cancer biomarker discovery: approaches and application.基于质谱的凝胶蛋白质组学在癌症生物标志物发现中的应用：方法与应用。
Theranostics. 2017 Aug 18;7(14):3559-3572. doi: 10.7150/thno.20797. eCollection 2017.
引用本文的文献
1
Mass Spectrometry Advancements and Applications for Biomarker Discovery, Diagnostic Innovations, and Personalized Medicine.质谱技术在生物标志物发现、诊断创新和个性化医学中的应用和进展。
Int J Mol Sci. 2024 Sep 12;25(18):9880. doi: 10.3390/ijms25189880.
本文引用的文献
1
An inflection point in high-throughput proteomics with Orbitrap Astral: analysis of biofluids, cells, and tissues.使用Orbitrap Astral实现高通量蛋白质组学的一个转折点：生物流体、细胞和组织分析
bioRxiv. 2024 Apr 27:2024.04.26.591396. doi: 10.1101/2024.04.26.591396.
2
Recent Advances of Proteomics in Management of Acute Kidney Injury.蛋白质组学在急性肾损伤管理中的最新进展
Diagnostics (Basel). 2023 Aug 11;13(16):2648. doi: 10.3390/diagnostics13162648.
3
Engineering protein-based therapeutics through structural and chemical design.通过结构和化学设计工程蛋白质类治疗药物。
Nat Commun. 2023 Apr 27;14(1):2411. doi: 10.1038/s41467-023-38039-x.
4
Proteomics in Drug Development: The Dawn of a New Era?药物研发中的蛋白质组学：新时代的曙光？
Proteomics Clin Appl. 2019 Mar;13(2):e1800087. doi: 10.1002/prca.201800087. Epub 2019 Feb 25.
5
Urinary Glycopeptide Analysis for the Investigation of Novel Biomarkers.尿糖肽分析用于新型生物标志物的研究。
Proteomics Clin Appl. 2019 May;13(3):e1800111. doi: 10.1002/prca.201800111. Epub 2018 Oct 18.
6
Personalized Proteomics: The Future of Precision Medicine.个性化蛋白质组学：精准医学的未来。
Proteomes. 2016;4(4). doi: 10.3390/proteomes4040029. Epub 2016 Oct 1.
7
Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration.基于组学的预测因子在临床试验中的应用标准：解释与说明。
BMC Med. 2013 Oct 17;11:220. doi: 10.1186/1741-7015-11-220.
Zotero 插件